top of page

Disease Outbreaks

In recent years, there have been global outbreaks of infectious diseases such as COVID-19, Mpox, and new strains of Influenza. The risk of new diseases emerging and spreading is always present. When suspected cases of a disease arise, samples must be sent to centralised laboratories for testing. It can take several days to even 1-2 weeks for results to be returned. This leads to critical delays in clinical management, as well as outbreak response and transmission control.

​

There is an urgent need for deployable point-of-care (POC) testing platforms that can be utilised to quickly identify suspected cases. These POC platforms need to be high-quality, rapid, and feature secure real-time data management that integrates with existing state and national surveillance and response systems.

​

By implementing rapid diagnostic capabilities at the POC, healthcare workers, public health officials, and emergency response teams can make immediate decisions regarding patient care, isolation protocols, contact tracing, and community prevention measures. This is vital for ensuring the best healthcare outcome for the patient, safeguarding public health and reducing the social and economic impacts of disease outbreaks.

Introducing the
ZiP-P2 Test System for Human Health

ZiP Diagnostics is developing tests for diseases: COVID-19, a respiratory panel, Hepatits C, and Mpox. These tests operate on the ZiP-P2 test platform. With its screen-guided workflow and automated results and reporting, the platform is designed for use in dedicated test spaces e.g. hospital emergency, intensive care, general practice, antiviral treatment clinics, or other sites established for testing purposes. This facilitates decentralised diagnosis.

​

ZiP tests provide PCR-comparable high sensitivity results in just 15-30 minutes. Test storage and test operation can be performed at room temperature, removing the need for a cold chain.

​

ZiP tests available for human health are:

  • ZiP-CoVx-P2 (SARS-CoV-2 test)​

TGA ARTG-LISTED (NUMBER: 478427) AND CE-MARKED. RESEARCH USE ONLY IN OTHER REGIONS. THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. PURCHASER DETAILS WILL BE VERIFIED BEFORE PRODUCT SHIPMENT.

​

ZiP tests in development for human health are:

  • ZiP-RESP-P2 (SARS-CoV-2, Flu A/B and RSV test)

  • ZiP-HCV-P2 (Hepatitis C test)

  • ZiP-MPx-P2 (Mpox test)​

Make fast, informed decisions onsite and in real time, for effective disease surveillance, clinical management, and transmission control.

Contact Us

24 Cromwell St, Collingwood

VIC 3066 • Australia

+61 (03) 8414 5770

  • X
  • LinkedIn

ZiP Diagnostics acknowledges the Wurundjeri Nation as the Traditional Custodians of the land on which our facilities are located. We offer our respects to their culture and Elders past, present and emerging. We welcome all cultures, nationalities and religions.

© 2025 ZiP Diagnostics, All rights reserved. ABN 52 635 536 551

bottom of page